Compass Therapeutics (CMPX) Current Assets (2023 - 2025)
Compass Therapeutics (CMPX) has disclosed Current Assets for 3 consecutive years, with $209.8 million as the latest value for Q4 2025.
- Quarterly Current Assets rose 58.05% to $209.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $209.8 million through Dec 2025, up 58.05% year-over-year, with the annual reading at $209.8 million for FY2025, 58.05% up from the prior year.
- Current Assets hit $209.8 million in Q4 2025 for Compass Therapeutics, down from $221.1 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $221.1 million in Q3 2025 to a low of $106.2 million in Q2 2025.
- Historically, Current Assets has averaged $160.6 million across 3 years, with a median of $156.2 million in 2023.
- Biggest YoY gain for Current Assets was 58.05% in 2025; the steepest drop was 30.84% in 2025.
- Year by year, Current Assets stood at $153.9 million in 2023, then dropped by 13.73% to $132.8 million in 2024, then soared by 58.05% to $209.8 million in 2025.
- Business Quant data shows Current Assets for CMPX at $209.8 million in Q4 2025, $221.1 million in Q3 2025, and $106.2 million in Q2 2025.